The presence of anti-Fc gamma receptor autoantibodies is related to the clinical presentation of primary Sjögren's syndrome

J Rheumatol. 1995 Dec;22(12):2241-5.

Abstract

Objective: Fc gamma receptor III (Fc gamma RIII) is one of the 3 structurally distinct families of receptors for the Fc domain of IgG, and its Fc gamma RIIIb isoform is exclusively expressed in polymorphonuclear (PMN) cells. We sought to detect anti-Fc gamma RIII autoantibodies in serum from patients with primary Sjögren's syndrome (SS).

Methods: Sixty-six patients with SS and 44 healthy controls were enrolled in the study. ELISA were developed.

Results: IgG and IgM autoantibodies were found in 16 (10 IgG+ IgM+ and 6 IgG+ IgM-) and 24 patients (10 IgG+ IgM+ and 14 IgG- IgM+) respectively. Their frequency was higher in patients with nonerosive arthritis (p < 0.02), Raynaud's phenomenon (p < 0.003), and lung involvement (p < 0.02) than in patients without such complications. The levels of IgM and IgG antibody (p < 0.05) correlated with the content of IgA without the circulating immune complex (IC), while there was no relationship between anti-Fc gamma RIII activity and the PMN count.

Conclusion: Anti-Fc gamma RIII autoantibodies may act as an acquired additional factor further compromising IC handling in individuals who share HLA-DR3 alloantigen.

MeSH terms

  • Adult
  • Aged
  • Autoantibodies / blood*
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • HLA-DR Antigens / analysis
  • Humans
  • Immunoglobulin Allotypes / analysis
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Immunoglobulins / immunology
  • Leukocyte Count
  • Male
  • Middle Aged
  • Receptors, IgG / biosynthesis
  • Receptors, IgG / immunology*
  • Recombinant Proteins
  • Rheumatoid Factor / blood
  • Sjogren's Syndrome / immunology*
  • Statistics, Nonparametric

Substances

  • Autoantibodies
  • HLA-DR Antigens
  • Immunoglobulin Allotypes
  • Immunoglobulin G
  • Immunoglobulin M
  • Immunoglobulins
  • Receptors, IgG
  • Recombinant Proteins
  • Rheumatoid Factor